Midwood
Kim S. Midwood, London GB
Patent application number | Description | Published |
---|---|---|
20110093082 | ENHANCED BONDING LAYERS ON TITANIUM MATERIALS - The present invention provides a dense-coverage, adherent phosphorous-based coating on the native oxide surface of a material. Disclosed phosphorous-based coatings include phosphate and organo-phosphonate coatings. The present invention also provides further derivatization of the phosphorous-based coatings to yield dense surface coverage of chemically reactive coatings and osetoblast adhesion-promoting and proliferation-promoting coatings on the native oxide surface of a titanium material. | 04-21-2011 |
Kim S. Midwood, Princeton, NJ US
Patent application number | Description | Published |
---|---|---|
20080206443 | ENHANCED BONDING LAYERS ON TITANIUM MATERIALS - The present invention provides a dense-coverage, adherent phosphorous-based coating on the native oxide surface of a material. Disclosed phosphorous-based coatings include phosphate and organo-phosphonate coatings. The present invention also provides further derivatization of the phosphorous-based coatings to yield dense surface coverage of chemically reactive coatings and osteoblast adhesion-promoting and proliferation-promoting coatings on the native oxide surface of a titanium material. | 08-28-2008 |
Kim S. Midwood, Littleborough GB
Patent application number | Description | Published |
---|---|---|
20120012033 | ENHANCED BONDING LAYERS ON TITANIUM MATERIALS - The present invention provides a dense-coverage, adherent phosphorous-based coating on the native oxide surface of a material. Disclosed phosphorous-based coatings include phosphate and organo-phosphonate coatings. The present invention also provides further derivatization of the phosphorous-based coatings to yield dense surface coverage of chemically reactive coatings and osetoblast adhesion-promoting and proliferation-promoting coatings on the native oxide surface of a titanium material. | 01-19-2012 |
Kim Suzanne Midwood, London GB
Patent application number | Description | Published |
---|---|---|
20130045212 | Biological Materials and Uses Thereof - There is provided agents for modulation of a chronic inflammatory response wherein the agent modulates the biological activity of tenascin-C. There is also provided methods of identifying agents modulating tenascin-C and chronic inflammation. There are also provided uses of such agents. | 02-21-2013 |
20130287760 | TREATMENT FOR DUPUYTREN'S DISEASE - Musculoskeletal fibroproliferative disorders, such as Dupuytren's disease may be treated by administering locally a TNF-α antagonist. TNF-α antagonists find particular utility in inhibiting the progression of early disease state Dupuytren's disease and other musculoskeletal fibroproliferative disorders and, in combination with extracellular matrix degradation agents (such ascollagenase or matrix metalloproteinase I), treating advanced disease state Dupuytren's disease and, in particular inhibiting recurrence. | 10-31-2013 |
20140322211 | TENASCIN-C AND USE THEREOF IN RHEUMATOID ARTHRITIS - The present invention provides a method of determining the rheumatoid arthritis status of a subject, or the progression of rheumatoid arthritis, or the appropriate treatment for a subject with rheumatoid arthritis, comprising the steps of (a) determining the level of tenascin-C in a sample from said subject; and (b) comparing the level of tenascin-C determined in step (a) with one or more reference values. Preferably the rheumatoid arthritis referred to is erosive rheumatoid arthritis. The be accompanied when published by FIG. | 10-30-2014 |